David Snyder - Jan 3, 2023 Form 4 Insider Report for Coya Therapeutics, Inc. (COYA)

Role: Chief Financial Officer
Signature: /s/ David Snyder
Stock symbol: COYA
Transactions as of: Jan 3, 2023
Transactions value $: $0
Form type: 4
Date filed: 1/4/2023, 07:30 AM
Previous filing: Dec 28, 2022
Next filing: Mar 1, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	COYA	Common Stock, par value $0.0001 per share	Purchase		+7K			7K	Jan 3, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	COYA	Warrant to Purchase Common Stock	Purchase		+3.5K			3.5K	Jan 3, 2023	Common Stock, par value $0.0001 per share	3.5K	$7.50	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reporting Person purchased 7,000 shares of Common Stock and an accompanying warrant to purchase 3,500 shares of Common Stock in the Issuer's initial public offering at a combined purchase price of $5.00 per share and accompanying warrant.